RPS3AP21 (Gene)

Entrez:402287

Description:RPS3A pseudogene 21

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View RPS3AP21's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with RPS3AP21.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using RPS3AP21.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for RPS3AP21.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with RPS3AP21.

Results found

Linked to

	Label	Description
	GSE261563 CX-5461 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173201 cisplatin 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173201 cisplatin 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE189772 GSE189773 CTB CTBp 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE189772 GSE189773 MHC FBXO11 inhibition CTBp 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE155836 GSE155839 YY1 knockdown Alvocidib 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155836 GSE155839 alvocidib 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE206931 WDR5 inhibition WIN 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE233112 doxorubicin 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 11 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE261563 CX-5461 3 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE173201 cisplatin 2 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE173201 cisplatin 2 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE189772 GSE189773 CTB CTBp 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE189772 GSE189773 MHC FBXO11 inhibition CTBp 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE155836 GSE155839 YY1 knockdown Alvocidib 3 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE155836 GSE155839 alvocidib 3 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE206931 WDR5 inhibition WIN 3 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE233112 doxorubicin 2 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE252944 AKT inhibition 11 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.